chr11-9574063-G-A
Variant summary
Our verdict is Likely benign. Variant got -6 ACMG points: 0P and 6B. BP4_ModerateBS2
The NM_003390.4(WEE1):c.130G>A(p.Gly44Ser) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000689 in 1,247,920 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_003390.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -6 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
WEE1 | NM_003390.4 | c.130G>A | p.Gly44Ser | missense_variant | 1/11 | ENST00000450114.7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
WEE1 | ENST00000450114.7 | c.130G>A | p.Gly44Ser | missense_variant | 1/11 | 1 | NM_003390.4 | P3 | |
WEE1 | ENST00000680141.1 | c.130G>A | p.Gly44Ser | missense_variant, NMD_transcript_variant | 1/12 |
Frequencies
GnomAD3 genomes AF: 0.0000332 AC: 5AN: 150436Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000240 AC: 1AN: 4168Hom.: 0 AF XY: 0.000455 AC XY: 1AN XY: 2198
GnomAD4 exome AF: 0.0000738 AC: 81AN: 1097484Hom.: 0 Cov.: 29 AF XY: 0.0000591 AC XY: 31AN XY: 524522
GnomAD4 genome AF: 0.0000332 AC: 5AN: 150436Hom.: 0 Cov.: 32 AF XY: 0.0000136 AC XY: 1AN XY: 73426
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 14, 2022 | The c.130G>A (p.G44S) alteration is located in exon 1 (coding exon 1) of the WEE1 gene. This alteration results from a G to A substitution at nucleotide position 130, causing the glycine (G) at amino acid position 44 to be replaced by a serine (S). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at